Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Zhang, L. et al. (2022) Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction. Circulation, 146(13), pp. 1411-1414. (doi: 10.1161/CIRCULATIONAHA.122.061481) (PMID:36029463)

[img] Text
276213.pdf - Accepted Version
Restricted to Repository staff only until 27 February 2023.

621kB

Abstract

No abstract available.

Item Type:Articles
Additional Information:The PARADIGM-HF and ATMOSPHERE trials, and this proteomic study, were funded by Novartis.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jhund, Professor Pardeep and McMurray, Professor John and Kober, Professor Lars
Authors: Zhang, L., Cunningham, J. W., Claggett, B. L., Jacob, J., Mendelson, M. M., Serrano-Fernandez, P., Kaiser, S., Yates, D. P., Healey, M., Chen, C.-W., Turner, G. M., Patel-Murray, N., Zhao, F., Beste, M. T., Laramie, J. M., Abraham, W. T., Jhund, P. S., Kober, L., Packer, M., Rouleau, J., Zile, M. R., Prescott, M. F., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., and Chutkow, W.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Circulation
Publisher:American Heart Association
ISSN:0009-7322
ISSN (Online):1524-4539
Published Online:27 August 2022
Copyright Holders:Copyright © 2022 American Heart Association, Inc.
First Published:First published in Circulation 146(18): 1411-1414
Publisher Policy:Reproduced in accordance with the publisher copyright policy
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record